U.S. stocks on the move: Mirum Pharmaceuticals, Meta, Boeing
SPY•U.S. stocks fell on Monday after President Donald Trump rejected an Iranian proposal to end the conflict, lifting crude prices and Treasury yields. Mirum Pharmaceuticals rose on an FDA approval, Meta retreated after a surge last week, and Boeing shares dropped after a report flagged a possible delivery hit from a software glitch.
1. Market declines
At 1:30 p.m. EDT, the Dow fell 0.44%, the S&P 500 dropped 0.55% and the Nasdaq Composite declined 0.64%. Crude prices spiked after Trump rejected an Iranian proposal to end the conflict, reviving inflation worries and driving Treasury yields higher.
2. Company moves
Mirum Pharmaceuticals rose after the FDA approved a drug for a rare bone disorder. Meta retreated after a surge last week. Boeing shares fell after Jefferies flagged a possible delivery hit tied to a software glitch report.
